glp-1 gastrointestinal obstruction lawsuit in michigan bowel class action Concerns have been raised about whether the delayed gastric emptying caused by GLP-1–based medications might jeopardize patient safety during Metabolic Syndrome: What It Is,

10.1186/s12970-019-0326-3 [DOI] [PMC free article] [PubMed] [Google Scholar] 66.Hidese S, Ogawa S, Ota M, Ishida I, Yasukawa Z, Ozeki M, et al

The era in which drug manufacturers, marketers and prescribers were separate entities that could be overseen separately is ending

The problem is, we dont really have a ton of concrete evidence to point to for any of these use cases

M.FranksA

Some may be digested to inactivity, while others may just not be absorbed well

Others work with benefits platforms for distribution, like Noom, which partnered with Collective Health, and WeightWatchers, which partnered with Personify Health